According to GuruFocus Insider Data, the recent CFO sales were: Texas Instruments Inc, Royal Caribbean Cruises Ltd, and Vertex Pharmaceuticals Inc.
Texas Instruments Inc. (TXN, Financial): Sr. Vice President and CFO Kevin P. March sold 318,750 shares
On 11/03/2014, Sr. Vice President and CFO Kevin P. March sold 318,750 shares at an average price of $50.01. The price of the stock has increased by 1.78% since. Texas Instruments Inc. has a market cap of $53.77 billion and its shares were traded at around $50.90. The company has a P/E ratio of 22.30 and P/S ratio of 4.33 with a dividend yield of 2.44%. Over the past 10 years, Texas Instruments Inc had an annual average earnings growth of 4.50%. GuruFocus rated Texas Instruments Inc the business predictability rank of 3-star.
Texas Instruments Inc. announced their 2014 second quarter results with revenues of $3.29 billion and gross profit of $1.9 billion; the net income was $683 million. The 2013 total revenue was $12.2 billion, a 5% decrease from the 2012 total revenue. The 2013 gross profit was $6.36 billion and the 2013 net income was $2.16 billion.
On 11/06/2014, SVP, Secretary and Gen Counsel Joseph F Hubach sold 109,375 shares at an average price of $50.85. The price of the stock has increased by 0.1% since. On 11/05/2014, Executive Vice President Brian T Crutcher sold 10,000 shares at an average price of $50.94. The price of the stock has decreased by 0.08% since. On 10/24/2014, Director Christine Todd Whitman sold 10,000 shares at an average price of $47.43. The price of the stock has increased by 7.29% since.
Royal Caribbean Cruises Ltd (RCL, Financial): CFO Jason T Liberty sold 13,531 shares
On 05/30/2014, CFO Jason T Liberty sold 13,351 shares at an average price of $55.39. The price of the stock has increased by 21.32% since. Royal Caribbean Cruises Ltd has a market cap of $14.96 billion and its shares were traded at around $67.20. The company has a P/E ratio of 22.70 and P/S ratio of 1.85 with a dividend yield of 1.56%. Over the past 10 years, Royal Caribbean Cruises Ltd had an annual average earnings growth of 1.60%. GuruFocus rated Royal Caribbean Cruises Ltd the business predictability rank of 2.5-star.
Royal Caribbean Cruises Ltd announced their 2014 third quarter results with revenues of $2.39 billion and gross profit of $961.88 million; the net income was $490.25 million. The 2013 total revenue was $7.96 billion, a 4% increase from the 2012 total revenue. The 2013 gross profit was $2.65 billion, a 5% increase from the 2012 gross profit. The 2013 net income was $473.7 million.
On 07/29/2014, Chairman and CEO Richard D Fain sold 94,850 shares at an average price of $62.38. The price of the stock has increased by 7.73% since. On 11/03/2014, 10% Owner Wilhelsmen A S A sold 7,000,000 shares at an average price of $67.45. The price of the stock has decreased by 0.37% since. On 11/03/2014, Director Arne Alexander Wilhelsmen sold 7,000,000 shares at an average price of $67.45. The price of the stock has decreased by 0.37% since.
Vertex Pharmaceuticals Inc. (VRTX, Financial): EVP and CFO Ian F Smith sold 108,026 shares
On 09/30/2014, EVP and CFO Ian F Smith sold 108,026 shares at an average price of $112.68. The price of the stock has increased by 2.88% since. Vertex Pharmaceuticals Inc. has a market cap of $27.88 billion and its shares were traded at around $115.93. The company has a P/S ratio of 34.30.
Vertex Pharmaceuticals Inc. announced their 2014 second quarter results with revenues of $138.4 million and gross profit of $121.1 million; the net income was $159.4 million. The 2013 total revenue was $1.21 billion, a 21% decrease from the 2012 total revenue. The 2013 gross profit was $1.1 billion, a 13% decrease from the 2012 gross profit. The 2013 net income was $445 million.
On 09/30/2014, CEO and President Jeffrey M Leiden sold 200,000 shares at an average price of $112.69. The price of the stock has increased by 2.88% since. On 11/06/2014, Director Bruce I Sachs sold 9,900 shares at an average price of $115.21. The price of the stock has increased by 0.62% since. On 11/05/2014, EVP and Chief Commercial Officer Stuart A Arbuckle sold 4,250 shares at an average price of $112.50. The price of the stock has increased by 3.05% since.
